Higher risk for amputation, DKA with SGLT2 inhibitors for T2DM
(HealthDay)—Use of sodium glucose cotransporter 2 (SGLT2) inhibitors is associated with an increased risk for lower-limb amputation and diabetic ketoacidosis compared with use of glucagon-like peptide 1 (GLP1) receptor ...
Nov 19, 2018
0
2